New adaptive clinical trial aims to reverse neurological damage caused by progressive multiple sclerosis |
|
|
|
|
|
The latest multiple sclerosis news from News Medical |
|
|
|
|
|
| | The first-ever adaptive clinical trial for Australians living with MS will seek to reverse neurological damage caused by progressive multiple sclerosis. | | | | Multiple sclerosis (MS), an inflammatory disease of the central nervous system, affects more than 1 million people in Europe and an estimated 2.8 million worldwide. | |
|
|
|
|